Compare XL Axiata Tbk. (EXCL) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
XL Axiata Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? XL Axiata Tbk. trades at Rp2,550 (market cap 46.05T, 3.6M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: XL Axiata Tbk. is far larger — about 78.8× UBC Medical Indonesia Tbk.'s market cap, and XL Axiata Tbk. is more actively traded (3.6M versus 817.3K). Which is the better fit depends on your goals.
| EXCL | LABS | |
|---|---|---|
Market Cap | 46.05T | 584.6B |
Volume | 3.6M | 817.3K |
Lot | 35.96K | 8.17K |
Turnover | 9.04B | 120.01M |
Average Price | 2,513.7 | 146.84 |
Value | 9.04B | 120.01M |
Indicative Equilibrium Price | 2,550 | 146 |
Indicative Equilibrium Volume | 977 | 59 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About XL Axiata Tbk.
PT XL Axiata Tbk (the Company) which was previously known as PT Excelcomindo Pratama Tbk, was initially established under the name PT Grahametropolitan Lestari. The Company was established on Oct 6th, 1989.The articles of association have been amended several times, most recently on Aug 2, 2005, concerning among other the change of par value, equity and public offering. The company started its operation since October 1996 and was the 3rd biggest company in Indonesia for the number of customer and income.
Read more on EXCL →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
